RPG Life Sciences Limited (BOM:532983)
India
· Delayed Price · Currency is INR 2,064.10
+92.55 (4.69%)
At close: Apr 11, 2025
RPG Life Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 10, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Market Capitalization | 38,592 | 25,279 | 11,585 | 9,269 | 6,407 | 2,808 | Upgrade
|
| Market Cap Growth | 63.52% | 118.21% | 24.98% | 44.67% | 128.15% | -31.49% | Upgrade
|
| Enterprise Value | 37,333 | 24,260 | 10,780 | 8,672 | 6,386 | 2,913 | Upgrade
|
| Last Close Price | 2317.70 | 1514.90 | 680.65 | 538.31 | 367.42 | 161.79 | Upgrade
|
| PE Ratio | 48.77 | 28.84 | 17.13 | 18.01 | 16.02 | 9.68 | Upgrade
|
| PS Ratio | 6.06 | 4.34 | 2.26 | 2.11 | 1.65 | 0.75 | Upgrade
|
| PB Ratio | 10.17 | 6.74 | 3.77 | 3.62 | 2.96 | 1.59 | Upgrade
|
| P/TBV Ratio | 10.91 | 7.29 | 4.22 | 4.19 | 3.57 | 2.09 | Upgrade
|
| P/FCF Ratio | - | 100.59 | 19.94 | 22.72 | 12.88 | 7.12 | Upgrade
|
| P/OCF Ratio | - | 26.79 | 12.76 | 14.32 | 11.00 | 5.60 | Upgrade
|
| EV/Sales Ratio | 5.86 | 4.17 | 2.10 | 1.97 | 1.64 | 0.78 | Upgrade
|
| EV/EBITDA Ratio | 24.54 | 19.08 | 10.53 | 10.25 | 9.34 | 5.17 | Upgrade
|
| EV/EBIT Ratio | 27.79 | 21.84 | 12.24 | 12.26 | 11.90 | 6.78 | Upgrade
|
| EV/FCF Ratio | - | 96.54 | 18.56 | 21.26 | 12.83 | 7.39 | Upgrade
|
| Debt / Equity Ratio | - | - | 0 | 0.00 | 0.01 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.00 | 0.01 | 0.03 | 0.20 | Upgrade
|
| Debt / FCF Ratio | - | - | 0 | 0.02 | 0.04 | 0.30 | Upgrade
|
| Asset Turnover | - | 1.25 | 1.34 | 1.36 | 1.37 | 1.45 | Upgrade
|
| Inventory Turnover | - | 1.93 | 1.98 | 2.08 | 2.58 | 3.01 | Upgrade
|
| Quick Ratio | - | 1.35 | 1.50 | 1.34 | 1.28 | 0.82 | Upgrade
|
| Current Ratio | - | 2.28 | 2.57 | 2.58 | 2.21 | 1.52 | Upgrade
|
| Return on Equity (ROE) | - | 25.69% | 24.01% | 21.80% | 20.36% | 17.21% | Upgrade
|
| Return on Assets (ROA) | - | 14.89% | 14.41% | 13.65% | 11.77% | 10.37% | Upgrade
|
| Return on Capital (ROIC) | 23.48% | 20.35% | 19.52% | 18.61% | 16.49% | 13.93% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 29.10% | 27.80% | 26.70% | 24.00% | 23.30% | Upgrade
|
| Earnings Yield | 2.05% | 3.47% | 5.84% | 5.55% | 6.24% | 10.33% | Upgrade
|
| FCF Yield | - | 0.99% | 5.01% | 4.40% | 7.77% | 14.04% | Upgrade
|
| Dividend Yield | 0.78% | 1.06% | 1.76% | 1.78% | 1.96% | 2.47% | Upgrade
|
| Payout Ratio | - | 22.64% | 23.48% | 23.14% | - | 36.50% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.77% | 1.06% | 1.76% | 1.78% | 1.96% | 2.47% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.